Tanya Monga

Ms. Tanya Monga serves as Chief Executive Officer. She has over 12 years of experience in biotechnology including both pharmaceuticals and diagnostics. Ms. Monga joined Roche in 2009 after experiences in startups in the US and UK as well as a Swiss bank. She has held roles with increasing responsibility in Roche, having worked in Switzerland, Colombia, Spain, and the US. Most recently, she served as Vice President, Lifecycle Leader for Neuroscience and Rare Diseases where she was responsible for fenebrutinib, starting 3 global phase III studies in multiple sclerosis. Ms. Monga earned a B.S. in Engineering Science, Nanoengineering from the University of Toronto, and an M.S. in Chemistry and Physics from McGill University.